The Cooper Companies, Inc.
COO
Ранг среди акций
#1935
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Цена акции
$57.43
Рыночная капитализация
$10.92B
Изменение (1 день)
-0.88%
Изменение (1 год)
-20.20%
Страна
US
Торговля The Cooper Companies, Inc. (COO)
Категория
Healthcare
EPS для The Cooper Companies, Inc. (COO)
EPS по состоянию на July 2026 TTM: $2.93
Согласно последним финансовым отчетам и цене акций The Cooper Companies, Inc., текущий EPS компании (TTM) составляет $2.93. В конце 2024 EPS компании составлял $1.97, больше, чем показателю 2023 года, равному $1.49.
История EPS компании The Cooper Companies, Inc. с 2000 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $2.93 | 55.85% |
| 2025 | $1.88 | -4.57% |
| 2024 | $1.97 | 32.21% |
| 2023 | $1.49 | -23.98% |
| 2022 | $1.96 | -96.72% |
| 2021 | $59.73 | 1,129.01% |
| 2020 | $4.86 | -48.68% |
| 2019 | $9.47 | 232.28% |
| 2018 | $2.85 | -62.65% |
| 2017 | $7.63 | 35.04% |
| 2016 | $5.65 | 34.52% |
| 2015 | $4.20 | -25.13% |
| 2014 | $5.61 | -7.88% |
| 2013 | $6.09 | 17.57% |
| 2012 | $5.18 | 38.50% |
| 2011 | $3.74 | 50.81% |
| 2010 | $2.48 | 11.21% |
| 2009 | $2.23 | 52.74% |
| 2008 | $1.46 | -684.00% |
| 2007 | $-0.25 | -116.78% |
| 2006 | $1.49 | -27.67% |
| 2005 | $2.06 | -27.21% |
| 2004 | $2.83 | 28.64% |
| 2003 | $2.20 | 37.50% |
| 2002 | $1.60 | 28.00% |
| 2001 | $1.25 | 22.55% |
| 2000 | $1.02 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $8.85 | 202.05% |
US
|
|
| $6.41 | 118.61% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 13.31% |
US
|
|
| - | - |
CH
|
